Blue California, a commercial partner of Conagen, expanded its health ingredient portfolio by scaling up and commercializing Conagen’s hydroxytyrosol
Blue California (Rancho Santa Margarita, CA), a commercial partner of Conagen (Bedford, MA), expanded its health ingredient portfolio by scaling up and commercializing Conagen’s hydroxytyrosol, a phenylethanoid ingredient found in olives and wine with antioxidant and anti-inflammatory properties.
“Hydroxytyrosol is derived from one of our four small-molecule platforms,” said Casey Lippmeier, PhD, vice president of innovation at Conagen, in a press release. “The flexibility of our phenolics platform has enabled us to rapidly scale and commercialize hydroxytyrosol and other novel ingredients, highlighting our productive innovation engine and reliability as a strategic service partner.”
Conagen’s hydroxytyrosol is colorless and odorless and is produced by using a cost-effective, sustainable natural fermentation process that has led to the filing of several patent applications.
“The Mediterranean diet is consistently rated as one of the healthiest diets, partially attributed to the use of olives,” said Blue California’s research, science and innovation officer Linda May-Zhang, PhD. “Hydroxytyrosol is one of the most potent antioxidants in olives, and research suggests the great promise of this molecule in healthy aging and potential immune support applications.”
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.